Madhu Kumar analyst GOLDMAN SACHS

Currently, out of the existing stock ratings of Madhu Kumar - 142 which are a Buy (66.98%), 49 which are a Hold (23.11%), 21 which are a Sell (9.91%)

Madhu Kumar

Work Performance Price Targets & Ratings Chart

Analyst Madhu Kumar works at GOLDMAN SACHS and is covering the Healthcare sector with 375 price targets and ratings displayed on 44 stocks. Previously, Madhu Kumar worked at BAIRD, B. RILEY, CHARDAN CAPITAL.

Madhu Kumar's average stock forecast success ratio is 55.45% with an average time for price targets to be met of 173.21 days.

Most recent stock forecast was given on IOVA, Iovance Biotherapeutics at 20-Nov-2023.

Wall Street Analyst Madhu Kumar

Analyst best performing recommendations are on CERE (CEREVEL THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARWR (ARROWHEAD PHARMACEUTICALS) at 11/25/2019. The price target of $70 was fulfilled within 4 days with a profit of $13.01 (22.83%) receiving and performance score of 57.07.

Average potential price target upside

ABUS Arbutus Biopharma ALNY Alnylam Pharmaceuticals APLS Apellis Pharmaceuticals ARCT Arcturus Therapeutics Holdings ARWR Arrowhead Pharmaceuticals CLVS Clovis Oncology DRNA Dicerna Pharmaceuticals EDIT Editas Medicine IOVA Iovance Biotherapeutics MGTA Magenta Therapeutics NTLA Intellia Therapeutics RGLS Regulus Therapeutics SNDX Syndax Pharmaceuticals APRE Aprea Therapeutics CLLS Cellectis KRYS Krystal Biotech PASG Passage Bio GRTS VIR Vir Biotechnology ACHN ALEC ARVN Arvinas AVEO AVEO Pharmaceuticals CERE Cerevel Therapeutics Holdings DVAX Dynavax Technologies EWTX FIXX MGEN RETA Reata Pharmaceuticals APLT HZNP Horizon Therapeutics PublicCompany JAZZ Jazz Pharmaceuticals plc SBPH TCDA Tricida CYTK Cytokinetics FULC ALNA ASMB Assembly Biosciences BOLD EIGR Eiger BioPharmaceuticals MDCO ONCE QURE uniQure N.V TTPH

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$3.97 (195.57%)


2 months 24 days ago

0/8 (0%)

$3.75 (150.13%)



$3.97 (195.57%)


5 months ago

0/3 (0%)

$4.35 (169.15%)



$2.94 (142.72%)

1 years 10 months 4 days ago

0/1 (0%)

$2.11 (73.01%)



2 years 5 months 8 days ago

0/2 (0%)

$6.88 (220.99%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Madhu Kumar is most bullish on?

Potential upside of $55.96 has been obtained for KRYS (KRYSTAL BIOTECH)

Which stock is Madhu Kumar is most reserved on?

Potential downside of -$2.48 has been obtained for ALEC

What Year was the first public recommendation made by Madhu Kumar?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart